Geneos Wealth Management Inc. - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 76 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$799
-8.2%
1000.0%0.00%
Q2 2023$8701000.0%0.00%
Q3 2022$01000.0%0.00%
Q2 2022$0
-100.0%
1000.0%0.00%
Q1 2022$1,0000.0%1000.0%0.00%
Q4 2021$1,0000.0%1000.0%0.00%
Q3 2021$1,0000.0%1000.0%0.00%
Q1 2021$1,0001000.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
WOODSTOCK CORP 22,253$514,2670.06%
MASSMUTUAL TRUST CO FSB/ADV 108$2,4960.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders